PRPF8 and hematopoietic and lymphoid system neoplasm: According to reports, alterations in other splicing factors, such as PRPF8, SF3A1, LUCL7L2, SF1, U2AF2, PRPF8, PRPF40B, SRSF6, SRSF1, SRSF7, TRA2β, SRRM2, DDX1, DDX23, and CELF4108,122–125 have very low frequencies among hematological tumors.